BCBS Arkansas

Does BCBS Arkansas cover Mounjaro?

Quick answer · Type 2 Diabetes

BCBS Arkansas covers Mounjaro for type 2 diabetes with prior authorization on Employer / Commercial Insurance and ACA Marketplace.

  • Employer / Commercial Insurance: Covered with requirements. A1C of 6.5% or higher
  • ACA Marketplace: Covered with requirements. A1C of 6.5% or higher

Last verified June 2, 2026. Source: C23650-D_GLP-1-Receptor-Agonist-BCBSAR.pdf. How we verify this data →

Check your card for your exact plan →

Mounjaro for Type 2 Diabetes

What BCBS Arkansas requires, by plan type. Open this indication on its own page →

Employer / Commercial Insurance

Covered with requirements

What you need to qualify

  • A1C of 6.5% or higher
  • Diagnosis documented with a code
  • Trial of metformin for at least 90 days, or a documented reason it can't be used (["intolerance", "contraindication", "combination_therapy_with_high_A1C"])
  • Lab results confirming eligibility

Qualification pathways

You can qualify through any one of these.

Initial Approval: T2DM diagnosis confirmed + metformin trial or exception

All of:

  • Diagnosis of type 2 diabetes mellitus confirmed by at least one of: A1C >= 6.5%, 2-hour plasma glucose >= 200 mg/dL during OGTT, symptoms of hyperglycemia with random plasma glucose >= 200 mg/dL, or FPG >= 126 mg/dL after fasting at least 8 hours

Plus any one of:

  • Trial of at least 90-day supply of metformin within past 360 days under CVS Caremark prescription benefit with inadequate treatment response (documentation required)
  • Intolerance or contraindication to metformin (documentation required)
  • Member requires combination therapy AND has A1C >= 7.5% (documentation required)

Documentation to bring

  • Medical record documenting T2DM diagnosis confirmed by at least one of: A1C >= 6.5%, 2-hour plasma glucose >= 200 mg/dL (OGTT), symptoms of hyperglycemia with random plasma glucose >= 200 mg/dL, or FPG >= 126 mg/dL after >= 8 hours fasting
  • Documentation of inadequate response to at least 90-day metformin trial within past 360 days (if applicable pathway)
  • Documentation of metformin intolerance or contraindication (if applicable pathway)
  • Documentation of A1C >= 7.5% if requesting combination therapy pathway
  • For continuation: documentation of A1C reduction since starting therapy
  • For continuation: documentation that member has been on therapy at least 3 months (samples excluded)

Approval and renewal

  • Renewal: every 12 months
  • To renew, the plan looks for improvement in A1C, Member must demonstrate a reduction in A1C since starting therapy. Member must also have been receiving the requested drug for at least 3 months (samples not counted). T2DM diagnosis confirmation is re-verified at continuation; however, the metformin trial and CV/CKD pathway requirements are not re-checked at renewal, and at least 12 weeks on therapy before the first renewal.

Policy note: If a claim is submitted with an approved ICD-10 code for type 2 diabetes mellitus under a CVS Caremark prescription benefit, the drug will be paid without requiring a PA. PA is only required if the appropriate ICD-10 code is absent. The document does not specify which ICD-10 codes are on the approved list. Mounjaro is listed in the policy header but has no special CV or CKD bypass pathways (those are only listed for Ozempic, Trulicity, and Victoza). Continuation approval duration is 1 year.

verified June 2, 2026 · source: C23650-D_GLP-1-Receptor-Agonist-BCBSAR.pdf

ACA Marketplace

Covered with requirements

What you need to qualify

  • A1C of 6.5% or higher
  • Diagnosis documented with a code
  • Trial of metformin for at least 90 days, or a documented reason it can't be used (["intolerance", "contraindication", "combination_therapy_with_high_A1C"])
  • Lab results confirming eligibility

Qualification pathways

You can qualify through any one of these.

Initial Approval: T2DM diagnosis confirmed + metformin trial or exception

All of:

  • Diagnosis of type 2 diabetes mellitus confirmed by at least one of: A1C >= 6.5%, 2-hour plasma glucose >= 200 mg/dL during OGTT, symptoms of hyperglycemia with random plasma glucose >= 200 mg/dL, or FPG >= 126 mg/dL after fasting at least 8 hours

Plus any one of:

  • Trial of at least 90-day supply of metformin within past 360 days under CVS Caremark prescription benefit with inadequate treatment response (documentation required)
  • Intolerance or contraindication to metformin (documentation required)
  • Member requires combination therapy AND has A1C >= 7.5% (documentation required)

Documentation to bring

  • Medical record documenting T2DM diagnosis confirmed by at least one of: A1C >= 6.5%, 2-hour plasma glucose >= 200 mg/dL (OGTT), symptoms of hyperglycemia with random plasma glucose >= 200 mg/dL, or FPG >= 126 mg/dL after >= 8 hours fasting
  • Documentation of inadequate response to at least 90-day metformin trial within past 360 days (if applicable pathway)
  • Documentation of metformin intolerance or contraindication (if applicable pathway)
  • Documentation of A1C >= 7.5% if requesting combination therapy pathway
  • For continuation: documentation of A1C reduction since starting therapy
  • For continuation: documentation that member has been on therapy at least 3 months (samples excluded)

Approval and renewal

  • Renewal: every 12 months
  • To renew, the plan looks for improvement in A1C, Member must demonstrate a reduction in A1C since starting therapy. Member must also have been receiving the requested drug for at least 3 months (samples not counted). T2DM diagnosis confirmation is re-verified at continuation; however, the metformin trial and CV/CKD pathway requirements are not re-checked at renewal, and at least 12 weeks on therapy before the first renewal.

Policy note: If a claim is submitted with an approved ICD-10 code for type 2 diabetes mellitus under a CVS Caremark prescription benefit, the drug will be paid without requiring a PA. PA is only required if the appropriate ICD-10 code is absent. The document does not specify which ICD-10 codes are on the approved list. Mounjaro is listed in the policy header but has no special CV or CKD bypass pathways (those are only listed for Ozempic, Trulicity, and Victoza). Continuation approval duration is 1 year.

verified June 2, 2026 · source: C23650-D_GLP-1-Receptor-Agonist-BCBSAR.pdf

Why Mounjaro requests get denied by BCBS Arkansas

Based on what this policy asks for. Fix these before the first submission.

  1. Wrong brand for the diagnosis. Mounjaro and Zepbound are the same molecule with different approved uses; a request for Mounjaro under a diagnosis that matches Zepbound is routinely denied.
  2. Diagnosis code missing or wrong on the request.
  3. No recent A1C result on file.
  4. No documented metformin trial (dose, dates, and outcome) or a stated reason it can't be used.

Frequently asked questions

Does BCBS Arkansas cover Mounjaro?
BCBS Arkansas covers Mounjaro for type 2 diabetes with prior authorization on Employer / Commercial Insurance and ACA Marketplace.
Do you have to try metformin before Mounjaro?
Yes for type 2 diabetes: BCBS Arkansas requires a documented trial of metformin of at least 90 days, or a documented reason it can't be used (["intolerance", "contraindication", "combination_therapy_with_high_A1C"]).
What does BCBS Arkansas require to renew Mounjaro?
Improvement in A1C, Member must demonstrate a reduction in A1C since starting therapy. Member must also have been receiving the requested drug for at least 3 months (samples not counted). T2DM diagnosis confirmation is re-verified at continuation; however, the metformin trial and CV/CKD pathway requirements are not re-checked at renewal, and at least 12 weeks on therapy before the first renewal.
How current is this information?
This page reflects BCBS Arkansas's written policy as of its current version, last verified against the source document on June 2, 2026.

Other medications under BCBS Arkansas

Mounjaro coverage under other plans

All insurance plans · All medications

This page summarizes BCBS Arkansas's written prior-authorization policy. It is not a guarantee of coverage; plans vary by employer and benefit design. Verify with your plan before relying on it.